First XEN implantation in Axenfeld- Rieger syndrome: A case report and literature review.

Axenfeld-Rieger syndrome Case report MIGS Secondary childhood glaucoma XEN implant

Journal

American journal of ophthalmology case reports
ISSN: 2451-9936
Titre abrégé: Am J Ophthalmol Case Rep
Pays: United States
ID NLM: 101679941

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 28 10 2021
revised: 06 03 2022
accepted: 08 03 2022
entrez: 22 3 2022
pubmed: 23 3 2022
medline: 23 3 2022
Statut: epublish

Résumé

To present the first report of a XEN45 gel stent implantation in a female with Axenfeld-Rieger syndrome (ARS), a rare congenital anomaly caused by abnormal neural crest migration during early embryogenesis. This shows promise as new minimally invasive therapeutic option in the treatment of secondary glaucoma in ARS. A 31-year-old female with known sporadic ARS was evaluated and treated at the Edith Wolfson Medical Center in Holon, Israel. The vision in her right eye was hand motion and 20/25 in the left eye. In the left eye the intraocular pressure (IOP) was up to 31 mmHg under maximal tolerated treatment. She refused Trabeculectomy or Glaucoma Drainage Device (GDD) surgery, but agreed to Minimally Invasive Glaucoma Surgery (MIGS). A Xen device was implanted in uneventful surgery. 15 months post operatively her IOP is 8 mmHg. XEN implantation, when technically feasible, is a suitable procedure in ARS. This shows promise as new minimally invasive therapeutic option in the treatment of secondary glaucoma in ARS. This has particular significance as these patients often require surgery at a young age.

Identifiants

pubmed: 35313473
doi: 10.1016/j.ajoc.2022.101486
pii: S2451-9936(22)00232-8
pmc: PMC8933667
doi:

Types de publication

Case Reports

Langues

eng

Pagination

101486

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

All authors have no financial disclosures: LM, RE, LN, MKL.

Références

J Curr Glaucoma Pract. 2020 Sep-Dec;14(3):87-92
pubmed: 33867756
J Glaucoma. 2017 Feb;26(2):e103-e104
pubmed: 27841796
Eur J Hum Genet. 2017 Nov;25(11):1290
pubmed: 29023440
BMC Ophthalmol. 2020 May 1;20(1):172
pubmed: 32357855
Medicine (Baltimore). 2017 Aug;96(33):e7791
pubmed: 28816964
Surv Ophthalmol. 1985 May-Jun;29(6):387-409
pubmed: 3892740
Trans Am Ophthalmol Soc. 1983;81:736-84
pubmed: 6676983
Eur J Hum Genet. 2009 Dec;17(12):1527-39
pubmed: 19513095
Curr Opin Ophthalmol. 2018 Mar;29(2):162-170
pubmed: 29319544
Am J Ophthalmol. 2000 Jul;130(1):107-15
pubmed: 11004268
Eye (Lond). 2016 Jul;30(7):936-42
pubmed: 27055677
Clin Ophthalmol. 2018 Apr 30;12:773-782
pubmed: 29750009

Auteurs

Liat Mendel (L)

Edith Wolfson Medical Center, 62 Halohamim st., Holon, Israel.

Ron Eremenko (R)

Edith Wolfson Medical Center, 62 Halohamim st., Holon, Israel.

Lilly Zborowski- Naveh (LZ)

Edith Wolfson Medical Center, 62 Halohamim st., Holon, Israel.

Maya Kalev-Landoy (M)

Edith Wolfson Medical Center, 62 Halohamim st., Holon, Israel.
Assuta HaShalom, 96 Yigal Alon st., Tel Aviv, Israel.

Classifications MeSH